Maintenance: Thursday, 22 March 2018, 18:00-18:15
Maintenance work on the ZORA servers is provided. There may be short interruptions in the service between 18:00 and 18:15. Thank you for your patience.
Ciardiello, F; Arnold, D; Casali, P G; Cervantes, A; Douillard, J-Y; Eggermont, A; Eniu, A; McGregor, K; Peters, S; Piccart, M; Popescu, R; Van Cutsem, E; Zielinski, C; Stahel, R (2014). Delivering Precision Medicine in Oncology Today and in Future-The Promise and Challenges of Personalised Cancer Medicine: a position paper by the European Society for Medical Oncology (ESMO). Annals of Oncology, 25(9):1673-1678.
Bottomley, A; Coens, C; Suciu, S; Santinami, M; Kruit, W; Testori, A; Marsden, J; Punt, C; Salès, F; Gore, M; Mackie, R; Kusic, Z; Dummer, R; Patel, P; Schadendorf, D; Spatz, A; Keilholz, U; Eggermont, A (2009). Adjuvant therapy with pegylated interferon alfa-2b versus observation in resected stage III melanoma: a phase III randomized controlled trial of health-related quality of life and symptoms by the European Organisation for Research and Treatment of Cancer Melanoma Group. Journal of Clinical Oncology, 27(18):2916-2923.